Mica AI Medical, an Israeli company offering technology for early breast cancer detection and diagnosis on contrast enhanced mammograms, has raised $3M in funding. Investors in the round include Haim Chizic, Tzachi Arabov, Daniel Koss, BNP VC, Israeli Innovation Authority, and the Ministry of Economy. Mica AI Medical ‘s system helps radiologists detect breast malignancies while interpreting contrast enhanced mammograms. The system…
Teal Health has raised $8.8M in seed funding from investors, including Emerson Collective, Serena Ventures, Metrodora Ventures, and Felicis Ventures, to build a women’s health platform focused on solving some of the most pressing issues in women’s health – starting with cervical cancer. Teal Health’s at-home cervical cancer screening includes a novel self-collection device that will make it simple for a woman…
Ovarian cancer is the deadliest gynecological disease. Up to 95% of women with ovarian cancer have symptoms for many months and consult a doctor, but the average time to diagnosis is 9 months. An early stage diagnostic test may enable detection of malignancy helping to expedite workup and treatment plans. Detection of ovarian cancer at early-stages has a 5-year survival rate of…
Forty percent of women in the U.S. have dense breast tissue, and they have a 4-6 times greater risk of developing breast cancer. Mammography alone misses about half the cancers in women with dense breasts, as dense tissue and cancer both appear white on mammogram images. Delphinus Medical Technology‘s SoftVue System is indicated for use as an adjunct to digital mammography in…
In June 2021 AOA Dx rasied $2.5M in seed funding after having participated in Y Combinator’s 2021 summer cohort. Yesterday the company announced another funding round, which now brings total funding to $7M. Participants in the latest round include Avestria Ventures, AlleyCorp, The Helm, RH Capital, Olive Tree Capital, Tencent. The new funds will be used to further develop the next generation…
Singapore-based digital health AI company FathomX, a spin-off company from the National University of Singapore (NUS) and National University Health System (NUHS), recently raised a Pre-series A fund of SGD $2.24M (ca. USD $2M) the lead up to Series A funding. Fathom X raised SGD$ 500K (ca. USD$ 350K) in a seed round in April 2021. Additionally, the I2Start Funding Program, a tripartite initiative to support company…
The German government has added a new prescription digital therapeutic to its DiGA program: “PINK! Coach supports breast cancer patients in changing their lifestyle towards more exercise, healthier nutrition and mindfulness in accordance with the current guideline recommendations. Via coaching modules, patients receive pseudo-individualized information, practical tips, instructions and exercises in the areas of exercise, nutrition and mental health.” The DiGa database is essentially a…
Sidekick Health and Eli Lilly are collaborating on an integrated digital therapeutics solution. The project marks the first phase of a relationship between Sidekick and Lilly, which starts with a digital therapeutic offering for patients battling breast cancer. The first phase will consist of the integrated digital therapeutic offering rollout in Germany. Reykjavik, Iceland-based Sidekick said the further expansion of its portfolio…
